SAN DIEGO, Aug. 18, 2017 -- For retail pharmacists looking to help consumers better manage their health and wellness, A&D Medical, a global leader in connected health and biometric measurement devices and services, is featuring its new line of ULTRACONNECT blood pressure monitors in the company’s booth (#4241) at the NACDS Total Store Expo (TSE) this weekend in San Diego.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/7cbde9a9-4874-4cc9-916a-10baede52c97
The new blood pressure monitors are an extension of the company’s commitment to evolving its product line to meet the needs of consumers – and their care providers – who are looking to monitor key aspects of health while keeping costs low.
“We know today’s retail pharmacists are trying to address the needs of a wide range of customers – from the extremely health conscious to patients struggling to manage a chronic condition,” said Terry Duesterhoeft, President and CEO of A&D Medical. “So before we designed this new line, we collected extensive consumer feedback. The result is what customers told us they want: an easy-to-use product that consistently delivers accurate measurements, paired with the ability to allow streamlined sharing of data with healthcare providers.”
The new A&D Medical ULTRACONNECT blood pressure monitors represent the premium end of the company's retail offering, and offer an unmatched set of features and capabilities including:
- A sleek, tubeless design that slips easily onto the wrist or arm;
- Light-weight, compact design allowing users to effortlessly transport the device wherever they go, ensuring they can consistently track and share blood pressure readings;
- Smart Connect feature automatically detects and connects the monitor to the company’s A&D Connect app for unparalleled ease of use;
- An offline, stand-alone operation, allows for the subsequent transfer of up to 100 readings to the A&D Connect app at a later time;
- A bright OLED display to provide illuminated feedback of measurement results;
- Multi-user support functionality for 5 users plus a guest; and
- Robust compatibility with both iOS and Android devices.
As with existing A&D Medical WellnessConnected devices, users will be able to operate the smart blood pressure monitors with their mobile device using the company’s free companion app – A&D Connect – designed to enhance the end-user experience with engaging and easy-to-use features such as graphing, trending, unlimited memory, reminders, and goal setting.
“The new product line leverages our more than four decades of experience in designing and delivering connected products to both the consumer and healthcare spaces – which is precisely where pharmacies sit in the spectrum of healthcare delivery,” said Mr. Duesterhoeft. “We look forward to sharing the ways we can help retail pharmacists as they care for their customers now and in the future.”
About A&D Medical
Since 1977, A&D Medical has manufactured and distributed a full line of advanced biometric monitoring solutions including blood pressure monitors, weight scales, activity monitors, and other health monitoring devices for consumer and professional use. A&D Medical is a worldwide leader in connected health and biometric measurement devices and services for consumer wellness and chronic condition management, marketing under the A&D brand globally and also the LifeSource brand in North America. A&D Medical is a division of A&D Company, a global manufacturer of measurement equipment, with operations around the globe. For general information about A&D Medical, please visit www.andmedical.com.
Please direct inquiries to: Liz Kohler, 414-828-6198 [email protected]


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Instagram Outage Disrupts Thousands of U.S. Users
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



